Articles

VRPX stock results show that Virpax Pharmaceuticals missed analyst estimates for earnings per share the fourth quarter of 2023. More

Auburn National Bancorp just reported results for the first quarter of 2024. More

Explore the dynamics of money-maker stocks in 2024, which are fueled by AI advancements and robust economic growth. More

Robotics stocks are currently stronger than other tech. Invest now and you will see your portfolio skyrocket in value. More

These three EV stocks are riddled with red flags, from endless dilution to unsustainable business models, making them prime EV stocks to sell. More

These are the undervalued blue-chip dividend stocks to buy that represent fundamentally strong stories with positive business outlooks. More

Investors have the potential to generate sizable returns with these top fintech stocks. Discover these promising opportunities. More

Subscriber Sign in